VABON is contraindicated in pregnant or nursing women and in patients with abnormal genital bleeding of unknown etiology. The drug is also contraindicated in patients with markedly impaired hepatic, renal, or cardiac function and in those with porphyria. VABON can induce aminoevulinate acid (ALA) synthetase activity and hence porphyrin metabolism.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
